Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01SQI
|
|||
| Former ID |
DIB013899
|
|||
| Drug Name |
POT-4
|
|||
| Synonyms |
AL-78898A; POT-4 EOS Insert; Compstatin complement-inhibiting peptides, Pennsylvania/Potentia; 4(1MeW)7W
Click to Show/Hide
|
|||
| Indication | Macular degeneration [ICD-11: 9B78.3; ICD-10: H35.3; ICD-9: 362.5] | Phase 2 | [1] | |
| Company |
University of Pennsylvania
|
|||
| Structure |
 |
Download2D MOL |
||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01157065) Evaluation of AL-78898A in Exudative Age-Related Macular Degeneration. U.S. National Institutes of Health. | |||
| REF 2 | Compstatin: A Complement Inhibitor on its Way to Clinical Application. Adv Exp Med Biol. 2008; 632: 273-292. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.